GlassScriptPhysician profile
Dhaval I Patel
NPI 1508152851
$5,209.27
in general payments reported to CMS, 2019-2025
18 companies · $539 in 2025
The $539 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $884 · 2024: $3,786 · 2025: $539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,610 · Food and Beverage: $2,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,609.76 |
| Food and Beverage | $2,599.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $1,902.00 | 2024-2025 | |
| Integra Lifesciences Corporation | $1,283.60 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medtronic, INC. | $222.66 | 2024-2025 | Accurian, Inceptiv |
| Horizon Therapeutics Plc | $212.69 | 2023 | Krystexxa |
| Inari Medical, INC. | $207.37 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Nevro Corp. | $206.07 | 2024 | Senza |
| Depuy Synthes Sales INC. | $190.30 | 2024-2025 | |
| Paratek Pharmaceuticals, INC. | $175.44 | 2023-2025 | Nuzyra |
| Averitas Pharma INC. | $158.49 | 2023-2025 | Qutenza |
| Stryker Corporation | $156.65 | 2023 | Prostep, Ortholoc 2 Lapifuse |
| Advanced Oxygen Therapy INC. | $143.63 | 2024 | Topical Oxygen Chamber For Extremities |
| Trilliant Surgical LLC. | $113.89 | 2024 | Arsenal Ankle 10 Hole 1/3 Tubular Plate |
| Smith+Nephew, INC. | $101.17 | 2023-2024 | Grafix, Collagenase Santyl, Stravix Pl |
| Tactile Systems Technology INC | $36.30 | 2023-2024 | Flexitouch Plus, Entre Plus |
| International Life Sciences | $35.21 | 2024 | Flexband |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $27.84 | 2023 | Puraply |
| Melinta Therapeutics, LLC | $21.76 | 2024 | Kimyrsa |
| Kowa Pharmaceuticals America, INC. | $14.20 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dhaval Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.